Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 01, 2010 (Vol. 30, No. 1)

Innovating Protein-Expression Systems

As Companies Diversify Portfolios, Production Processes Need to Be Retooled

  • There has been a maturation of the bioprocessing industry as companies have moved away from a focus on anticancer biologics toward a more diversified portfolio of pharmacological agents. With this diversity of disease targets comes a need for expression technologies to fit the requirements of proteins that may be ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.